<?xml version="1.0" encoding="UTF-8"?>
<p id="par0125">Zhou Zhongying, a traditional Chinese medicine expert for infectious disease, and his research team are also paying attention to SSHT. Zhou Zhongying is a scholar who has been studying traditional Chinese herbal medicine treatment for various epidemic diseases (including SARS) for about 70 years.
 <xref rid="bib0275" ref-type="bibr">
  <sup>55</sup>
 </xref> Recently, Zhou Zhongying and his research team prepared a summary report, Traditional Chinese Medicine Differentiation and Treatment of New Coronavirus Pneumonia in Jiangsu Province (Version 3) based on the clinical data obtained after the epidemic of COVID-19.
 <xref rid="bib0280" ref-type="bibr">
  <sup>56</sup>
 </xref> This report h
 <bold>a</bold>d been verified by relevant experts in Jiangsu Province, China. The report gives guidelines on prescribing treatments based on the disease stage, and all of the prescriptions that were recommended for the early to middle stages of COVID-19 are based on SSHT (Early stage: SSHT + Gwakbakharyeongtang (GBHRT, 
 <italic>Huo Pu Xia Ling Tang</italic> in Chinese, 
 <italic>Katsubokukaryoto</italic> in Japanese), Middle stage with pattern of heat toxin and stagnant lung: SSHT + GBHRT + MHGST).
</p>
